Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.5081
-0.0181 (-3.44%)
Feb 5, 2026, 3:33 PM EST - Market open
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $20.07 million as of February 5, 2026. Its market cap has decreased by -76.05% in one year.
Market Cap
20.07M
Enterprise Value
-55.27M
1-Year Change
-76.05%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $20.07M, an increase of 115.78%. That is a compound annual growth rate of 8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 20.80M | -20.31% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 21.64M |
| Intensity Therapeutics | 21.64M |
| CollPlant Biotechnologies | 21.46M |
| NanoViricides | 20.78M |
| Genenta Science | 20.71M |
| CASI Pharmaceuticals | 20.34M |
| IO Biotech | 19.89M |
| Jupiter Neurosciences | 19.60M |